菩人丹超微粉对糖尿病大鼠视网膜血流动力学和细胞因子表达的影响

doi:10.13481/j.1671-587x.20190111

摘要/Abstract

摘要： 目的：探讨菩人丹超微粉（简称PRD）对糖尿病大鼠视网膜血流动力学和细胞因子表达的影响，阐明PRD对糖尿病视网膜病变（DR）的保护作用。方法：36只雄性SD大鼠随机分为对照组、糖尿病组和PRD组，每组12只。糖尿病组和PRD组大鼠腹腔内注射链脲佐菌素（STZ）建立糖尿病模型。建模成功后，PRD组大鼠灌胃给予PRD （1.8 g·kg^-1），连续3个月。采用多普勒超声检测大鼠视网膜中央动脉（CRA）血流动力学参数，采用逆转录聚合酶链反应（RT-PCR）检测视网膜组织中血管内皮生长因子（VEGF）和碱性成纤维细胞生长因子（bFGF） mRNA表达水平，采用免疫组织化学染色法和Western blotting法检测视网膜组织中VEGF和bFGF蛋白表达水平。结果：与对照组比较，糖尿病组大鼠血糖、尿量、肝指数和肾指数明显升高（P<0.05），视网膜CRA峰血流速度（PSV）、舒张期末流速（EDV）和平均血流速度（MV）明显降低（P<0.05），阻力指数（RI）和搏动指数（PI）明显升高（P<0.05），视网膜组织中VEGF和bFGF mRNA及蛋白表达水平明显升高（P<0.05）。与糖尿病组比较，PRD组大鼠血糖、尿量、肝指数和肾指数明显降低（P<0.05），视网膜CRA的PSV、EDV和MV明显升高（P<0.05），RI和PI明显降低（P<0.05），视网膜组织中VEGF和bFGF mRNA及蛋白表达水平明显降低（P<0.05）。结论：PRD可降低糖尿病大鼠血糖水平，增加视网膜组织血供，增加微循环血液灌注量，降低血管床灌注阻力，下调VEGF与bFGF表达，对糖尿病视网膜微血管损伤起保护作用。

关键词: 糖尿病,实验性, 糖尿病视网膜病变, 菩人丹超微粉, 血流动力学, 血管内皮生长因子, 碱性成纤维细胞生长因子

Abstract: Objective: To investigate the effects of Purendan Superfine Powder(PRD) on the retinal hemodynamics and the expressions of cytokines in the diabetic rats, and to elucidate its protective effect on diabetic retinopathy(DR).Methods: Thirty-six male SD rats were randomly divided into control group, diabetes group, and PRD group(n=12). The diabetes rat models were established by intraperitoneal injecting streptozotocin(STZ) in diabetes group and PRD group. After successful modeling, the diabetic rats in PRD group were given PRD (1.8 g ·kg^-1) by gavage for 3 months. The hemodynamics parameters of central retinal artery(CRA) of the rats were measured with color Doppler ultrasound. The expression levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) mRNA in retina tissue were detected by reverse transcription polymerase chain reaction (RT-PCR). Immunohistochemical staining and Western blotting methods were used to detect the expression levels of VEGF and bFGF proteins in retina tissue of the rats.Results: Compared with control group, the blood glucose, urine volume, liver index and kidney index of the rats in diabetes group were significantly increased(P<0.05), the peak systolic velocity(PSV), end diastolic velocity(EDV) and mean velocity(MV) of CRA were significantly decreased(P<0.05), the resistant index(RI) and pulsatility index(PI) of CRA were significantly increased(P<0.05), and the expression levels of VEGF and bFGF mRNA and protein in retina tissue were significantly increased(P<0.05). Compared with diabetes group, the blood glucose, urine volume, liver index and kidney index of the rats in PRD group were significantly decreased(P<0.05), the PSV, EDV and MV of CRA were increased(P<0.05), the RI and PI of CRA were decreased(P<0.05), the expression levels of VEGF and bFGF mRNA and protein in retina tissue were significantly reduced(P<0.05).Conclusion: PRD can protect the diabetic retinal microvascular injury by reducing the blood glucose level, increasing the blood supply of retinal tissue, increasing the amount of microcirculation blood perfusion, reducing the vascular bed perfusion resistance, and reducing the expression of VEGF and bFGF.

Key words: diabetes mellitus,experiment, diabetic retinopathy, Purendan Superfine Powder, hemodynamics, vascular endothelial growth factor, basic fibroblast growth factor

中图分类号:

R285.5

王海彬, 董志军, 郭立涛, 石晶, 董薇丽. 菩人丹超微粉对糖尿病大鼠视网膜血流动力学和细胞因子表达的影响[J]. 吉林大学学报(医学版), 2019, 45(01): 57-62.

WANG Haibing, DONG Zhijun, GUO Litao, SHI Jing, DONG Weili. Effects of Purendan Superfine Powder on retinal hemodynamics and expressions of cytokines in diabetic rats[J]. Journal of Jilin University(Medicine Edition), 2019, 45(01): 57-62.

参考文献

[1] 张凤俊, 易敬林, 李晶明, 等. 糖尿病视网膜病变发病机制研究进展[J]. 眼科新进展, 2016, 36(6):584-587.
[2] 左舒颖, 倪青. 2型糖尿病病证结合治疗体会[J]. 北京中医药, 2017, 36(6):537-540.
[3] 陈阳, 张丽华, 封敏. 中西医结合治疗糖尿病视网膜病变82例临床观察[J]. 实用临床医药杂志, 2015, 19(11):180-181.
[4] 庞宗然, 苏晓慧, 刘祖涵, 等. 菩人丹超微粉对T2DM大血管病变大鼠主动脉形态结构的影响[J]. 辽宁中医杂志, 2011, 38(10):1923-1925,2112.
[5] 刘祖涵, 张梓倩. 菩人丹对T2DM胰腺微血管损伤大鼠胰岛β细胞功能及胰岛素抵抗的影响[J]. 天津中医药, 2016, 33(7):414-418.
[6] 贾明利, 李庆雨. VEGF、bFGF在糖尿病视网膜病变中的表达及意义[J]. 中国实用医药, 2017, 12(21):37-39.
[7] CHOI S M,LEE K M,KIM H J, et al. Effects of structurally stabilized EGF and bFGF on wound healing in type Ⅰ and type Ⅱ diabetic mice[J]. Acta Biomater, 2017, 66:325-334.
[8] 张自然, 董志军, 董微丽,等. 中药菩人丹对OLETF大鼠视网膜磷酸化c-Jun氨基末端激酶和半胱氨酸天冬氨酸激酶-3表达的干预作用[J]. 中成药, 2016, 38(6):1397-1401.
[9] 刘学梅, 靳春杰, 周伟. 三七对糖尿病大鼠视网膜血流动力学影响的实验研究[J]. 辽宁中医杂志, 2017,44(10):2183-2186,2240.
[10] 董娜, 金智生. 论益气养阴、活血化瘀法在糖尿病治疗中的应用[J]. 中医药临床杂志, 2018, 30(1):15-16..
[11] 王鑫蕊, 郭鑫瞳, 刘广鹏, 等. 南征教授滋阴清热、益气养阴、活血化瘀法治疗消渴病[J]. 长春中医药大学学报, 2017, 33(2):269-271.
[12] 白颖慧, 杜子亮, 陈书,等. 菩人丹改善高糖波动状态下INS-1细胞胰岛素分泌功能的分子机制[J]. 中国中医基础医学杂志, 2016, 22(12):1620-1624,1637.
[13] 张垒, 董志军, 张铁民. 菩人丹超微粉对2型糖尿病大鼠血糖和血脂的影响[J]. 承德医学院学报, 2012, 29(1):20-22.
[14] 朱汝霞, 黄炫庚, 陈冰, 等. 检测2型糖尿病患者颈动脉流体动力学和血清炎症因子的意义[J]. 海南医学院学报, 2017, 23(6):752-754,758.
[15] 陈小红, 王云鹏, 陈梅珠. VEGF和PEDF在增殖性糖尿病视网膜病变中的研究进展[J]. 国际眼科杂志, 2015, 15(1):55-57.
[16] WANG L J,XIAO F,KONG L M, et al. Intermedin enlarges the vascular lumen by inducing the quiescent endothelial cell proliferation[J]. Arterioscler Throm Vas Biol, 2018, 38(2):398-413.
[17] GALLEGO-MUÑOZ P, IBARES-FRÍAS L,GARROTE A,et al. Human corneal fibroblast migration and extracellular matrix synthesis during stromal repair:Role played by platelet-derived growth factor-BB, basic fibroblast growth factor, and transforming growth factor-β1[J]. J Tissue Eng Regen Med, 2018, 12(2):737-746.
[18] WATANABE A,KURABAYASHI M,ARAI M, et al. Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells[J]. Cardiovasc Res, 2001, 51(1):151-159.
[19] SZYBERT S,MOSZYNSKI R,MICHALAK S, et al. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors[J]. Microvasc Res, 2016, 107:91-96.
[20] 郑晓燕,唐纯志.针灸对实验性糖尿病小鼠心脏功能调节的影响[J].西安交通大学学报:医学版,2018,39(5):765-769.
[21] PAVLISA G,PAVLISA G,KUSEC V, et al. Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD[J]. Eur Cytokine Netw, 2010, 21(2):92-98.